Intravascular Catheters Market Report 2025

This Intravascular Catheters market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The intravascular catheters market size has grown rapidly in recent years. It will grow from $7.51 billion in 2024 to $8.49 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to increased aging population, rise in cardiovascular diseases, adoption of minimally invasive procedures, healthcare digitalization, global health initiatives.

The intravascular catheters market size is expected to see rapid growth in the next few years. It will grow to $13.78 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to growth of precision medicine, sustainable healthcare, expansion of telemedicine, patient education and engagement, increased use of intravascular catheters. Major trends in the forecast period include smart catheters, advanced navigation systems, vascular access in pediatrics, artificial intelligence (ai)-assisted catheter placement, advancements in non-invasive catheter procedures.

The growth of the intravascular catheters market is being propelled by the increasing hospitalization rate attributed to the high prevalence of chronic diseases. Globally, the prevalence of chronic illnesses is on the rise, leading to a heightened demand for intravascular catheters. These catheters play a crucial role in obtaining samples for tests and facilitating the intake of fluids, nutrients, and blood during the treatment of chronic diseases. Fresenius Medical Care, a German healthcare company, estimates that the number of individuals suffering from chronic kidney failure is expected to increase from 3.7 million patients in 2021 to 4.9 million by 2025. Consequently, the escalating hospitalization rate due to the prevalence of chronic diseases is anticipated to drive the growth of the intravascular catheters market in the years to come.

The growing demand for long-term care is anticipated to drive the growth of the intravascular catheters market in the coming years. Long-term care (LTC) encompasses a range of services and support provided over an extended period to individuals who face challenges in performing daily activities due to chronic illnesses, disabilities, cognitive impairments, or other conditions. Many individuals receiving long-term care require ongoing medication regimens to manage chronic conditions such as diabetes, heart disease, or infections. Intravascular catheters, including central venous catheters (CVCs) and peripherally inserted central catheters (PICCs), enable healthcare providers to deliver medications directly into the bloodstream, ensuring precise dosing and minimizing the need for frequent injections. For example, in October 2022, the National Health Service, a UK-based government agency, reported that in 2021-2022, 8 out of every 1,000 people aged 18-64 received long-term support. Thus, the rising demand for long-term care is fueling the growth of the intravascular catheters market.

A notable trend in the intravascular catheters market is the emphasis on product innovations by major industry players. Companies are actively focusing on introducing new products with advanced features to enhance their market position. For example, B. Braun Medical Inc., a German-based medical and pharmaceutical device manufacturing company, introduced the Introcan Safety 2 IV Catheter in July 2022. This catheter incorporates one-time blood control, enhancing safety for clinicians by reducing the risk of blood exposure and needle stick accidents. Another instance is the introduction of the Shockwave M5+ catheter by Shockwave Medical Inc. in March 2022. This catheter is specifically designed to treat calcified lesions in various arteries, addressing challenges in treatment.

Major companies in the intravascular catheters market are leveraging new technologies, such as AI-enabled intravascular ultrasound, to enhance profitability. AI-enabled intravascular ultrasound (IVUS) integrates artificial intelligence with conventional IVUS imaging to provide more precise and comprehensive information about a patient's blood vessels. Evident Vascular Inc., a US-based ultrasound technology company, launched AI-enabled intravascular ultrasound in October 2023. The Evident Vascular Guidance System, powered by artificial intelligence, improves imaging quality, enabling healthcare professionals to obtain more accurate pictures of blood artery interiors. AI-enabled IVUS technology aids in the identification and treatment of venous and arterial illnesses, thereby improving patient outcomes.

In May 2024, Johnson & Johnson, a US-based company specializing in pharmaceuticals, biotechnology, and medical technologies, acquired Shockwave Medical, Inc. for $13.1 billion. This acquisition is intended to bolster its cardiovascular portfolio. The deal aims to enhance J&J's capabilities in treating coronary artery disease by integrating Shockwave's innovative intravascular lithotripsy technology. Shockwave Medical, Inc. is a US-based medical device company that develops intravascular catheters.

Major companies operating in the intravascular catheters market include Cook Group Incorporated, Smiths Medical Inc., Edwards Lifesciences Corporation, Medtronic Inc., Johnson & Johnson, Abbott Laboratories, Boston Scientific Corporation, Cordis Corporation, Koninklijke Philips NV, Terumo Corporation, ACIST Medical Systems Inc., B. Braun Melsungen AG, Teleflex Incorporated, Hollister Incorporated, Coloplast Corp., ConvaTec Inc., Merit Medical Systems Inc., ICU Medical Inc., AngioDynamics Inc., Vygon SA, Becton, Dickinson and Company, C. R. Bard Inc., Teleflex Medical OEM, Nipro Medical Corporation, Argon Medical Devices Inc., Vascular Solutions Inc., Infus Medical (India) Pvt. Ltd., Angiplast Pvt. Ltd., Romsons Scientific & Surgical Pvt. Ltd., Hindustan Syringes & Medical Devices Ltd.

North America was the largest region in the intravascular catheters market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravascular catheters market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the intravascular catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

An intravascular catheter is a device generally made up of a hollow fiber that allows blood to flow through and an immunoisolating membrane that separates the transplanted cells from the blood. These catheters are utilized for administering fluids, medications, blood products, and nutrition, typically inserted into a large vein in the arm or chest.

The main products in the intravascular catheter category include short peripheral intravenous catheters (PIVC) and integrated/closed PIVC. Short PIVCs are those that are less than or equal to 3 inches in length and are commonly used for intravenous medication administration, predominantly in general wards. The various applications of intravascular catheters encompass oncology, gastroenterology, renal disease, infectious diseases, and others, with end-users including hospitals, clinics, ambulatory surgical centers, and homecare.

The intravascular catheters market research report is one of a series of new reports that provides intravascular catheters market statistics, including intravascular catheters industry, global intravascular catheters market size, regional shares, competitors with an intravascular catheters market share, detailed intravascular catheters market segments, market trends and opportunities, and any further data you may need to thrive in the intravascular catheters industry. This intravascular catheter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The intravascular catheters market consists of sales of pulmonary artery catheters and pacing wires. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.